These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 22167613

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of IgA nephropathy with chronic renal failure].
    Pozzi C.
    G Ital Nefrol; 2008; 25 Suppl 44():83-7. PubMed ID: 19048591
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C, Del Vecchio L, Locatelli F.
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy].
    Horino T, Ito H, Tanimoto N, Yoshida T, Sasaoka A, Chijiwa T, Hosokawa T, Hashimoto K.
    Nihon Jinzo Gakkai Shi; 2003 Jul; 45(2):104-8. PubMed ID: 12703406
    [Abstract] [Full Text] [Related]

  • 15. Treatment of IgA nephropathy: an update.
    Rosselli JL, Thacker SM, Karpinski JP, Petkewicz KA.
    Ann Pharmacother; 2011 Oct; 45(10):1284-96. PubMed ID: 21954446
    [Abstract] [Full Text] [Related]

  • 16. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Amemiya N, Ochi A, Tsuruta Y, Shimizu A, Itabashi M, Takei T, Uchida K, Nitta K.
    Am J Nephrol; 2011 Oct; 34(3):233-40. PubMed ID: 21778707
    [Abstract] [Full Text] [Related]

  • 17. Idiopathic membranous nephropathy: diagnosis and treatment.
    Fervenza FC, Sethi S, Specks U.
    Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q, Shi SF, Zhu L, Lv JC, Liu LJ, Chen YQ, Zhang H, Wang HY.
    Am J Nephrol; 2012 May; 35(4):312-20. PubMed ID: 22456060
    [Abstract] [Full Text] [Related]

  • 19. Antiproteinuric effect of olmesartan in patients with IgA nephropathy.
    Tomino Y, Kawamura T, Kimura K, Endoh M, Hosoya T, Horikoshi S, Utsunomiya Y, Yasuda T, Toyoda M, Tsuge T, Kaneko K.
    J Nephrol; 2009 May; 22(2):224-31. PubMed ID: 19384840
    [Abstract] [Full Text] [Related]

  • 20. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.